Elucidating the specific pharmacological mechanism of action (MOA) of naturally taking place compounds may be difficult. Whilst Tarselli et al. (60) developed the main de novo synthetic pathway to conolidine and showcased this naturally developing compound correctly suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic goal https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers